Exit Seminar: Bacteria-Engineered Vasicles for Cancer Immunotherapy: From Immunomodulation in Vitro to Anti-Tumor Effects in Melanoma Models
Bacterial vesicles hold immense potential in various biomedical fields, including vaccines, antimicrobial agents, drug delivery systems, and cancer immunotherapy. Among these, outer membrane vesicles (OMVs) produced by Gram-negative bacteria are among the most extensively studied. While the exact mechanism of OMV production remains unclear, numerous environmental factors have been shown to influence both the yield and composition of OMVs. In this study, we investigated the effect of three different antimicrobial families on OMV production by E. coli. Interestingly, antimicrobials within the same family did not provide the same effects on OMV yield, suggesting that OMV production may not directly correlate with the antimicrobial mechanism of action.
OMVs have demonstrated tumor-inhibitory activity in multiple mouse tumor models. However, their potential toxicity poses a significant challenge, as OMVs have been shown to cause mortality in mice. To address this limitation, we developed bacterial-engineered vesicles (BEVs) as a safer alternative to OMVs. Proteomic analysis revealed that BEVs contained fewer outer membrane proteins compared to OMVs. In vitro assays, BEVs effectively repolarized pro-tumor macrophages (M2) to the anti-tumor phenotype (M1) and promoted dendritic cell maturation. Additionally, BEVs were shown to serve as a versatile platform for antigen peptide display, with the displayed peptides not interfering with BEVs' inherent immunomodulatory activity.
We further evaluated the anti-tumor efficacy of BEVs in a B16F10 melanoma model. The intravenous administration of BEVs significantly inhibited tumor growth and elicited robust immune responses. Flow cytometry analysis of spleen and lymph node samples from BEV-treated mice revealed an elevated M1/M2 macrophage ratio and an increased population of CD8+ T cells. To explore combination therapies, we generated cancer cell-derived vesicles (PD-1 CEVs) using PD-1-transfected B16F10 cells. Interestingly, while BEVs alone inhibited tumor growth effectively, the co-administration of BEVs and PD-1 CEVs resulted in comparable tumor suppression but attenuated immune responses. However, a significant decrease in regulatory T cell percentages was monitored among all vesicle-treated groups compared to the PBS control group. This unexpected immune modulation warrants further investigation to understand the mechanisms underlying PD-1 CEV-mediated immune suppression.
Zoom link:
| One tap mobile: | US: +16694449171,,81671850412# or +16699006833,,81671850412# |
| Meeting URL: | |
| Meeting ID: | 816 7185 0412 |
Small molecule metal complexes have diverse applications including usage as catalysts, single molecule magnets, photosensitizers and pharmaceuticals. Nature itself frequently takes advantage of such complexes for fundamental biological processes. For example, heme-based iron complexes provide O2 for cellular respiration, while the active site of carbonic anhydrase catalyzes the hydration of CO2. Now it is our turn to define and exploit the chemical characteristics of such metal complexes. This body of work is specific to the development and application of novel aminated ligands that, when coordinated to various metal centers, can be used for an assortment of applications. The first research project in this work reports a new benzimidazole-based ligand, which dimerizes upon coordination to afford a trinuclear Cu(I) complex. Due to the linear geometry of the Cu(I) metal centers, paired with the strong nitrogen coordinating groups, the resulting complex is resistant to oxidation in both air and water, even in the presence of strong oxidants. The complex is shown to be efficient in the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction and used to tag anticancer drug candidates in vitro. The complex is fully characterized, and a catalytic cycle is proposed. The next project focuses on a series of amidine-based ligands featuring chiral functional groups proximal to the coordinating site. In doing so, the reaction of achiral substrates may be influenced to promote the formation of one enantiomeric product over the other. The ligands are shown to be active in catalyzing the hydroxymethylation of silyl enol ethers in the presence of bismuth chloride in aqueous solutions. The reaction is optimized and yields are reported. In the final research project, Ni(II) dimer complexes are investigated for their magnetic behavior. For octahedral Ni(II) dimers bridged by a common anion, it has previously been established that the ferromagnetic superexchange between the Ni(II) metal centers can be enhanced as the angle of the bridging anion approaches 90 degrees. Novel imidazole and pyridine-based ligands are synthesized to add to the catalogue of chlorine-bridged complexes in the literature. Further, their bromine-bridged analogues are synthesized in order to determine the effect the identity of the halide bridge has on the magnetic properties of the complex. These three projects, while functionally different with individual aims, fundamentally share the goal of probing the chemical space that influences intrinsic properties of unique metal complexes.
Global CO2 emissions from industrial, power generation and transportation sources has led to the call for increased implementation of carbon capture strategies. The most developed of these is point source carbon capture, which refers to the process of capturing CO2 directly from large (point) source emitters, before the CO鈧 is released into the atmosphere. The challenge becomes separating CO2 from the other components of the emitted gas, mainly nitrogen. Therefore, these processes typically involve the use of aqueous solutions of amines to absorb (capture) CO鈧 from the gas stream, where the CO2 and the basic amine in water react to form a carbamate and/or bicarbonate, depending on the specific amine used. An advantage when using amine solutions is that this reaction is reversible, as the absorbed CO2 is released when the solution is heated allowing the amine to be reused in multiple cycles of absorption and regeneration.
